Neuronetics chases new depression approval; DiaGenic tanks on Alzheimer's Dx failure;

@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev

@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce

@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce

> Neuronetics has kicked off a clinical trial to test how well its NeuroStar brain-stimulation device can treat women with postpartum depression. More

> Norwegian diagnostics outfit DiaGenic ($DIAG) watched its shares plummet more than 50% after its Alzheimer's test failed to meet its endpoints in a study. Article

> Life Technologies ($LIFE) has signed a 5-year deal with the FDA to use its diagnostics technology for food safety testing. News

> Regions in India are beginning to ban the use of mercury-based medical products. Story

> Implant Sciences has moved into much larger headquarters and manufacturing space in Wilmington, MA. Item

> EPGL Medical says it has developed a self-powered, self-contained power source for contact lenses that could enable, in part, the display of medical data such as blood sugar or oxygen levels. Item

> Conspiracy theories are mushrooming regarding the unexpected death of Barnaby Jack, a computer hacker who demonstrated security flaws in insulin pumps and other medical devices. Story

> Philips Healthcare ($PHG) is looking to establish an incubator for medical startups in Israel. Story

Biotech News

@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech

@RyanMFierce: UPDATED: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce

@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce

> Sanofi, NEA team up in $18M round for rare disease outfit Edimer. Story

> Celgene inks $11M inflammation deal with Array BioPharma. News

> Synta Pharma rebounds on early results from drug study for breast cancer. Article

Pharma News

@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma

@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce

> Suffering from generic onslaught, Merck cuts sales forecast. Story

> Sanofi's bid for more OTC meds gets FDA boost. Article

> Moody's cuts GlaxoSmithKline outlook, citing billions in outlays. Report

Biotech Research News

@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce

> Novavax joins H7N9 vaccine race, reports positive preclinical data. News

> Antibody effective at fighting norovirus in chimps. Story

> Novavax joins H7N9 vaccine race, reports positive preclinical data. Article

> Antibody effective at fighting norovirus in chimps. More

Pharma Manufacturing News

@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce

> Cadila Pharma selects site for $150M Russian plant. News

> Alexion adding 50 jobs in Ireland to grow global supply chain. Item

> Pfizer says investments in Ireland position plants for growth. More

> New Russian company to build $85M plant. Story

> Bristol-Myers turns to Samsung for cancer drug. Article

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.